About the journal
Trends in Molecular Medicine is a journal published by Elsevier BV in United Kingdom. It is listed in MEDLINE according to the sources read. Declared publication charge: 6,830 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier BV
- ISSN
- 1471-499X · 1471-4914
- Country
- United Kingdom
- Access
- Not open access / not declared
- Declared publication charge
- 6,830 USD
- Declared peer-review model
- peer_review
- Official website
- https://www.journals.elsevier.com/trends-in-molecular-medicine
Index listings
- MEDLINE · 2001-01-01
- Indexing
- MEDLINE
- APC
- 6,830 USD
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 69 days received→accepted — computed from PubMed (n=100)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
3207
Last recorded publication year
2026
h-index
238
i10-index
1997
From OpenAlex open data (CC0).
Editorial & policy4
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 81%
- ORCID iDs in current deposits
- 68%
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 100966035
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Diverse Scientific and Economic Studies
- Diverse Scientific and Economic Studies
- Human auditory perception and evaluation
- Human auditory perception and evaluation
- Legal Cases and Commentary
- Legal Cases and Commentary
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
Show all subjects (50)
- Legal case studies and regulations
- Legal case studies and regulations
- CRISPR and Genetic Engineering
- CRISPR and Genetic Engineering
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- T-cell and B-cell Immunology
- T-cell and B-cell Immunology
- Virus-based gene therapy research
- Mitochondrial Function and Pathology
- Virus-based gene therapy research
- Mitochondrial Function and Pathology
- RNA Interference and Gene Delivery
- RNA Interference and Gene Delivery
- RNA modifications and cancer
- RNA modifications and cancer
- Pluripotent Stem Cells Research
- Pluripotent Stem Cells Research
- Educational Robotics and Engineering
- Educational Robotics and Engineering
- CAR-T cell therapy research
- CAR-T cell therapy research
- Alzheimer's disease research and treatments
- Alzheimer's disease research and treatments
- MicroRNA in disease regulation
- Neuroinflammation and Neurodegeneration Mechanisms
- Neuroinflammation and Neurodegeneration Mechanisms
- MicroRNA in disease regulation
- RNA Research and Splicing
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Pharmacy and Medical Practices
- Pharmacy and Medical Practices
- RNA Research and Splicing
- Ubiquitin and proteasome pathways
- Ubiquitin and proteasome pathways
- Cancer-related Molecular Pathways
- Cancer-related Molecular Pathways
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ